Should I buy or sell Alliance Pharma stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alliance Pharma in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" APH shares. View APH analyst ratings or view top-rated stocks .

What is Alliance Pharma's stock price target for 2024?

3 analysts have issued 12 month target prices for Alliance Pharma's stock. Their APH share price targets range from GBX 53 to GBX 105. On average, they anticipate the company's stock price to reach GBX 87.67 in the next twelve months. This suggests a possible upside of 121.9% from the stock's current price. View analysts price targets for APH or view top-rated stocks among Wall Street analysts .

How have APH shares performed in 2023?

Alliance Pharma's stock was trading at GBX 53 at the beginning of the year. Since then, APH stock has decreased by 25.5% and is now trading at GBX 39.50. View the best growth stocks for 2023 here .

How often does Alliance Pharma pay dividends? What is the dividend yield for Alliance Pharma?

Alliance Pharma announced a dividend on Tuesday, March 21st. Shareholders of record on Thursday, June 22nd will be given a dividend of GBX 1.18 per share on Tuesday, July 18th. This represents a yield of 2.06%. The ex-dividend date is Thursday, June 22nd. This is a positive change from the stock's previous dividend of GBX 0.59. The official announcement can be accessed at this link . Read our dividend analysis for APH .

Is Alliance Pharma a good dividend stock?

Alliance Pharma (LON:APH) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 3.75%. Read our dividend analysis for APH .

What other stocks do shareholders of Alliance Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alliance Pharma investors own include RPC Group (RPC) , American Airlines Group (AAL) , BlackBerry (BB) , Editas Medicine (EDIT) , 1-800-FLOWERS.COM (FLWS) , Air Canada (AC) , Ally Financial (ALLY) , Aviva (AV) , BAE Systems (BA) and Berry Global Group (BERY) .

How do I buy shares of Alliance Pharma?

Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

Alliance Pharma (APH) Share Price, News & Analysis

GBX 39.50

+0.75 (+1.94%)

(As of 04:35 PM ET)

Compare

Today's Range: 38
▼
39.75
50-Day Range: 34.50
▼
46.60
52-Week Range: 33.70
▼
73.04

Volume: 593,841 shs
Average Volume: 1.87 million shs
Market Capitalization: £213.45 million

P/E Ratio: N/A
Dividend Yield: 5.06%
Price Target: GBX 87.67

Stock Analysis Analyst Forecasts Chart Competitors Dividend Headlines Insider Trades

Alliance Pharma MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 121.9% Upside
GBX 87.67 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
£1.64 M Sold Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Alliance Pharma has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 87.67, Alliance Pharma has a forecasted upside of 121.9% from its current price of GBX 39.50.
Amount of Analyst Coverage
Alliance Pharma has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for APH.

1.7

Dividend Strength

Dividend Leadership
Alliance Pharma is a leading dividend payer. It pays a dividend yield of 3.75%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Alliance Pharma does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for APH.

0.6

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Alliance Pharma this week, compared to 0 articles on an average week.
Search Interest
12 people have searched for APH on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Alliance Pharma insiders have sold more of their company's stock than they have bought. Specifically, they have bought GBX 0 in company stock and sold £16,400.67 in company stock.
Percentage Held by Insiders
Only 9.79% of the stock of Alliance Pharma is held by insiders.
Percentage Held by Institutions
73.42% of the stock of Alliance Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Alliance Pharma is -3,950.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Alliance Pharma is -3,950.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Alliance Pharma has a PEG Ratio of 1.04. PEG Ratios around 1 indicate that a company is correctly valued.
Price to Book Value per Share Ratio
Alliance Pharma has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Alliance Pharma Stock (LON:APH)

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.

APH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

APH Stock News Headlines

December 6, 2023 | americanbankingnews.com

Alliance Pharma (LON:APH) Stock Price Passes Below 200-Day Moving Average of $47.01

November 30, 2023 | markets.businessinsider.com

Ascendis Pharma’s Growth Potential Bolstered by Strategic Partnership and Product Pipeline

December 11, 2023 | DTI Trader (Ad)

All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

November 23, 2023 | morningstar.com

Alliance Pharma PLC APH

November 11, 2023 | uk.investing.com

Alliance Pharma (ALAPH)

October 19, 2023 | finance.yahoo.com

Calculating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

June 2, 2023 | fool.co.uk

Should you invest in Mark Slater favourite Alliance Pharma right now?

May 28, 2023 | msn.com

Numis Reiterates Alliance Pharma (LSE:APH) Buy Recommendation

December 11, 2023 | Autonomix (Ad)

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

March 24, 2023 | finance.yahoo.com

Earnings Miss: Alliance Pharma plc Missed EPS By 95% And Analysts Are Revising Their Forecasts

March 18, 2023 | fool.co.uk

3 dirt cheap growth shares to buy right now?

February 9, 2023 | finance.yahoo.com

Alliance Pharma plc's (LON:APH) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

January 19, 2023 | finance.yahoo.com

Is Alliance Pharma plc (LON:APH) Trading At A 49% Discount?

December 3, 2022 | finance.yahoo.com

Alliance Pharma plc (LON:APH) is a favorite amongst institutional investors who own 85%

October 24, 2022 | finance.yahoo.com

Shareholders in Alliance Pharma (LON:APH) are in the red if they invested a year ago

September 20, 2022 | finance.yahoo.com

Edited Transcript of ALAPH.L earnings conference call or presentation 20-Sep-22 8:30am GMT

September 7, 2022 | apnews.com

Love Pharma Initiates First Steps Towards a Strategic Alliance with Starton Therapeutics with Investment in this Biotech Leader

September 2, 2022 | fool.co.uk

Alliance Pharma

September 2, 2022 | finance.yahoo.com

Are Alliance Pharma plc's (LON:APH) Mixed Financials Driving The Negative Sentiment?

August 13, 2022 | marketwatch.com

U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia

August 8, 2022 | marketwatch.com

Alliance Pharma Names New Auditor After KPMG Resigns Over Corporate Concerns

June 2, 2022 | uk.finance.yahoo.com

The Alliance Pharma share price – where next?

May 16, 2022 | finance.yahoo.com

Investors in Alliance Pharma (LON:APH) have made a solid return of 148% over the past five years

May 14, 2022 | fool.co.uk

7 top AIM market shares to buy now

March 26, 2022 | finance.yahoo.com

Can Mixed Fundamentals Have A Negative Impact on Alliance Pharma plc (LON:APH) Current Share Price Momentum?

January 19, 2022 | lse.co.uk

Alliance Pharma earnings up on increased revenue, e-commerce activity

January 19, 2022 | finance.yahoo.com

Is There An Opportunity With Alliance Pharma plc's (LON:APH) 48% Undervaluation?

See More Headlines

Receive APH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:APH
CUSIP: N/A
CIK: N/A
Web: www.alliancepharma.co.uk
Phone: +44-1249-466966
Fax: N/A
Employees: 285
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: GBX 87.67
High Stock Price Target: GBX 105
Low Stock Price Target: GBX 53
Potential Upside/Downside: +121.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX (0.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 7.09
P/E Growth: 1.04
Net Income: £12.18 million
Net Margins: 0.56%
Pretax Margin: N/A
Return on Equity: 0.33%
Return on Assets: 3.42%

Debt

Debt-to-Equity Ratio: 47.83
Current Ratio: 2.24
Quick Ratio: 1.42

Sales & Book Value

Annual Sales: £167.42 million
Price / Sales: 1.27
Cash Flow: GBX 5.02 per share
Price / Cash Flow: 7.87
Book Value: GBX 53 per share
Price / Book: 0.75

Miscellaneous

Outstanding Shares: 540,390,000
Free Float: N/A
Market Cap: £213.45 million
Optionable: Not Optionable
Beta: 0.56

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Andrew Timothy Franklin (Age 57)
Interim CEO, CFO & Executive Director
Comp: $271.52k
Mr. Peter Jonathan Butterfield (Age 47)
CEO & Executive Director (Leave of Absence)
Comp: $399.83k
Mr. Jeyan Heper (Hons)
BA, COO & Director
Mr. Stephen Kidner
Chief Scientific Affairs Officer
Ms. Cora Maeve McCallum C.F.A.
Head of Investor Relations & Corporate Communications
Mr. Christodoulos Theoclis Chrysanthou
Group General Counsel & Company Secretary
Mr. Alex Duggan
Chief Commercial & Corporate Development Officer
Ms. Janice Timberlake
Chief People & Infrastructure Officer
Chris Delafield
Global Marketing Head of Kelo-Cote
Rhodri Smith
Head of Sourcing

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

APH Stock Analysis - Frequently Asked Questions

Should I buy or sell Alliance Pharma stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alliance Pharma in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" APH shares.
View APH analyst ratings or view top-rated stocks.
What is Alliance Pharma's stock price target for 2024?: 3 analysts have issued 12 month target prices for Alliance Pharma's stock. Their APH share price targets range from GBX 53 to GBX 105. On average, they anticipate the company's stock price to reach GBX 87.67 in the next twelve months. This suggests a possible upside of 121.9% from the stock's current price.
View analysts price targets for APH or view top-rated stocks among Wall Street analysts.
How have APH shares performed in 2023?: Alliance Pharma's stock was trading at GBX 53 at the beginning of the year. Since then, APH stock has decreased by 25.5% and is now trading at GBX 39.50.
View the best growth stocks for 2023 here.
How often does Alliance Pharma pay dividends? What is the dividend yield for Alliance Pharma?: Alliance Pharma announced a dividend on Tuesday, March 21st. Shareholders of record on Thursday, June 22nd will be given a dividend of GBX 1.18 per share on Tuesday, July 18th. This represents a yield of 2.06%. The ex-dividend date is Thursday, June 22nd. This is a positive change from the stock's previous dividend of GBX 0.59. The official announcement can be accessed at this link.
Read our dividend analysis for APH.

Is Alliance Pharma a good dividend stock?: Alliance Pharma (LON:APH) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 3.75%.
Read our dividend analysis for APH.
What other stocks do shareholders of Alliance Pharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Alliance Pharma investors own include RPC Group (RPC), American Airlines Group (AAL), BlackBerry (BB), Editas Medicine (EDIT), 1-800-FLOWERS.COM (FLWS), Air Canada (AC), Ally Financial (ALLY), Aviva (AV), BAE Systems (BA) and Berry Global Group (BERY).
How do I buy shares of Alliance Pharma?: Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:APH) was last updated on 12/11/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Alliance Pharma (APH) Share Price, News & Analysis

Alliance Pharma MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Alliance Pharma Stock (LON:APH)

APH Stock Price History

APH Stock News Headlines

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

APH Stock Analysis - Frequently Asked Questions

Overall MarketRank^™